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Background: Rearrangements involving the short arm of chromosome 18 have been extensively described. Here
we report a microduplication of 320.5–431.5 Kb at 18p11.31-p11.23 in a 10 year-old boy.
Case presentation: In a 10 year-old boy with moderate psychomotor delay, hypoplasia of the cerebellar
vermis, chorioretinal coloboma, deafness and growth hormone deficiency (GHD), an interstitial
microduplication at 18p11.31-p11.23 was identified by array-CGH. This maternally inherited microduplication,
encompasses three genes, namely ARHGAP28, LINC00668 and LAMA1 (a gene involved in cerebellum and
retinal development).
Conclusions: The genotype-phenotype is discussed with particular attention to the LAMA1 gene, although it
is difficult, as in many other similar situations, to assess the causality of the detected duplication in the
absence of further studies aiming to explore the presence of co-occurring variants that could explain the
incomplete penetrance.
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Rearrangements involving the short arm of chromosome
18 have been extensively described in the literature [1].
In most cases, patients carrying deletions of the whole
arm (18p-syndrome), with breakpoints close to the
centromeric region have been reported. The primary
features of this condition include a cognitive impairment
of varying severity, speech delay, short stature, holopro-
sencephaly, ptosis, pectus excavatum and dysmorphic
features [2, 3]. Pituitary hormone deficiencies have also
been reported [4, 5]. Conversely, 18p duplications are
rare events in cytogenetic findings and only few cases
are represented by pure duplications [1], being associ-
ated in most of the patients with 18q s or resulting from* Correspondence: mauro.bozzola@unipv.it
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locations. For these patients, the phenotypic features
could be the result of the excess of chromosome 18p
material along with the imbalance of other chromosome
regions.
Interestingly, there have been no reports of large inter-
stitial duplication of 18p; nevertheless, with the
introduction of microarrays some microduplications,
with a likely pathogenic effect, have been identified. An
18p11.31-p11.32 duplication of 429.5 Kb, including four
genes, among which the likely causative EMILIN2, has
been identified in a family with porokeratosis of Mibelli
[6]. In the same region, other authors [7] detected a
larger overlapping 2.6 Mb microduplication involving at
least nine genes in two siblings with variable levels of
intellectual disability/developmental delay and behavioral
difficulties. Finally, Kashevarova et. al [8] reported ale is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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autism and dysmorphisms.
Here we report a microduplication of 320.5–431.5 Kb
at 18p11.31-p11.23 identified through array comparative
genomic hybridization (aCGH), not overlapping with the
previously described one, encompassing three genes,
namely ARHGAP28, LINC00668 and LAMA1 in a 10
year-old boy with moderate psychomotor delay, hypopla-
sia of the cerebellar vermis, chorioretinal coloboma,
deafness and growth hormone deficiency (GHD). The
functional role of laminin alpha 1 in cerebellum and
retinal development suggests that the duplication of
LAMA1 may be responsible for at least some of the
patient’s clinical features.
Case presentation
A 7.5 year-old boy, the second child of non-
consanguineous Caucasian healthy parents (father
33 years-old, with a height of 161.5 cm and mother
36 years-old, 166.1 cm) was referred to our Department
because of short stature. His height was 110 cm (−2.25
standard deviation score (SDS), weight 17 Kg (body
mass index (BMI) −4.78 SDS) and bone age 6.5 years.
An intrauterine growth restriction was documented by
ultrasound scan between the 20th and 22nd week of
gestation. Labor was induced due to interruption of fetal
development and fetal distress at 33 weeks. The birth
weight was 1,450 g (−1.81 SDS), birth length 41 cm
(−1.49 SDS) and head circumference 28 cm (−2.29 SDS).
Apgar scores were 6 and 9 at 1 and 5 min. He required
intubation and mechanical ventilation because of
pneumothorax. He was discharged from the Neonatal
Intensive Care Unit after 37 days with the diagnosis ofFig. 1 a Dismorphic features of the patient at 7.5 years of age. Microce
micrognathia, esotropia, epicanthus, right palpebral ptosis are shown. b
substitutive therapychorioretinal coloboma. The patient’s family history was
not significant for chromosome abnormalities, develop-
mental delay or intellectual disability. His 3 year-old
sister was healthy.
At 1 year of age, brain magnetic resonance image
(MRI) showed lateral and third ventricle enlargement,
stenosis of the aqueduct of Silvio and decrease dimen-
sions of cerebellar vermis. These pathologic features
were later confirmed by further MRI.
The patient had a history of significant developmental
delay and intellectual disability. He sat at 13 months and
walked at 2 years. He achieved language acquisition at 4
years and required speech therapist and psychologist
care. At the age of 6 year the patient was diagnosed with
bilateral mixed hypoacusis. At the age of 9.5 years, his
intelligence quotient (IQ) was 49.
He presented dysmorphic features including micro-
cephaly, triangular face, high forehead, protruding low
set ears, small teeth, micrognathia, esotropia, epicanthus,
right palpebral ptosis and flat feet (Fig. 1a).
At the age of 7.5 years, he was investigated because of
short stature. After exclusion of celiac disease, malab-
sorption, inflammatory bowel disease, hypothyroidism
and other chronic diseases, GH response to two
pharmacological stimuli (arginine and glucagon)
revealed a GHD (GH peaks: 4.8 and 8.1 ng/ml, respect-
ively; normal values >10 ng/ml). No other pituitary
hormone deficiencies were found to be associated. MRI
of the hypothalamic-pituitary region revealed a flattened
pituitary gland (Fig. 2a, b). Substitutive GH therapy
(0.21 mg/Kg subdivided into 6 weekly subcutaneous
injections) was started and led to a satisfactory increase
in height (Fig. 1b).phaly, triangular face, high forehead, protruding low set ears,
Height curve of the subject. The arrow indicates the start of GH
Fig. 2 Magnetic resonance imaging of the hypothalamic-pituitary region. Flattened pituitary gland. a coronal view. b sagittal view
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Array Comparative Genomic Hybridization (aCGH)
analysis
DNA was extracted from whole blood of the patient by salt-
ing out method and the Concentration and purity was mea-
sured with the NanoDrop spectrophotometer (NanoDrop
Technologies, Inc.). Array CGH was performed using the
standard Agilent Human Genome G3 SurePrint 4 × 180 K
Microarray (Agilent Technologies, California, USA), with
median spacing of 13 Kb. Labeling and hybridization were
carried out according to the manufacturer’s instruction
(Agilent Technologies, California, USA).
The image of the array was acquired using the Agilent
laser scanner G2565CA (Agilent Technologies, California,
USA) and analyzed with the Agilent Feature Extraction
software (v10.10.1.1.). Results were analyzed by Agilent
Cytogenomics software (v2.5.8.11).
The presence of the duplication was confirmed in the
patient and searched in his relatives through MLPA
(Multiplex Ligation Probe Amplification) with a probe
specifically designed within LAMA1 (chr18:7014093–
7014542; GRCh37/hg19) using the SALSA MLPA probe-
mix P200-A1 Human DNA Reference-1 (MRC-Holland).
Copy number variations (CNVs) reported in the Database
of Genomic Variants [9] were excluded from further
analysis.
We performed a search in DECIPHER database [10]
and ClinGen [11] to search for patients carrying similar
micro-duplications.
Sequencing
The CDH7 and LIG4 genes were screened for the pres-
ence of causative mutations by direct sequencing. Briefly,
genomic DNA was amplified by polymerase chain reac-
tion (PCR) using primers designed to specifically amplify
the coding regions and the intron/exon boundaries of
each gene (see Additional file 1) The PCR products werevisualized on a 2% agarose gel and purified using
ExoSAP-IT enzymatic PCR clean up system (Affimetrix,
Santa Clara, CA). The purified products were, then,
sequenced with the Big Dye Terminator kit (Applied
Biosystems, Foster City, CA) and the automatic
sequencer ABI PRISM 3100 Genetic Analyzer (Applied
Biosystems, Foster City, CA).Results
At the age of 8 years, short stature, reduced head
circumference, cognitive delay and facial dysmorphisms
led to investigation of the LIG4 gene involved in Dubow-
itz syndrome (OMIM #223370): no mutation was identi-
fied. Because of clinical features including chorioretinal
coloboma, growth failure, developmental retardation and
hearing loss, CHARGE syndrome (OMIM#214800) was
suggested at the age of 9 years. Sequencing of the
CHD7, whose mutation explains about 90% of cases of
CHARGE syndrome, excluded this gene as the cause of
the patient’s phenotype.
The array-CGH performed at the age of 10 years showed
the presence of an interstitial microduplication at
18p11.31-p11.23 (6,813,085 × 2, 6,825,044–7,157,962 × 3,
7,193,872 × 2) of 332,9–380,7 Kb (Fig. 3a). The same dupli-
cation, tested through MLPA, was present in the mother of
the patient, but not in the father and in the older sister
(Fig. 3b). Actually, the apparently healthy mother upon a
closer evaluation revealed some mild clinical features of the
son, such as partially hearing loss and mild micrognathia.
She had a normal head size and her performance at school
was within the normal range.
The duplicated region was examined using the human
resource websites at NCBI [12] and the archive
EnsEMBL [13]. This region contains 3 genes, encoding
for a member of the Rho guanosine triphosphatases
(ARHGAP28), the laminin subunit α1 (LAMA1) and a
Fig. 3 18p11.31-p11.23 duplication. a Pedigree of the family. The arrow indicates the proband. dup = duplication, wt = absence of the duplication.
b Graphic representation of part of 18p11.23-p11.31 (corresponding to the region included in red box depicted in the chromosome 18 ideogram)
with the genes included in this region. The duplication detected in our patient at 18p11.31-p11.23 18p11.23-p11.31 (6,813,085 × 2, 6,825,044–7,157,962 × 3,
7,193,872 × 2) -ranging from 332,9 to 380,7 Kb is represented by a green rectangle above the boxed region. Genomic positions refer to the Human
Genome February 2009 assembly (GRCh37/hg19). c Schematic representation of the microduplications (smaller than 2.7 Mb) in this region reported in the
DECIPHER and ISCA database. The ID of each patient is reported. The clinical features of the patients are reported in parentheses below the corresponding
duplication as described in Decipher [10] and ClinGen [11]
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known function.
Conclusions
Most microdeletions and microduplications encompass
several genes with various functions, creating a challenge
in understanding the role of the genes involved in the
phenotype. Occasionally, however, these mutations
encompass only few genes. Such cases are of special
interest in contributing to the understanding of effects
of dosage variations of the included genes.
Here we report a 18p micro-duplication including
three genes in a patient with intellectual disability, deaf-
ness, GHD and other clinical features. The duplication
was inherited from the unaffected mother. In contrast tomicrodeletions, the interpretation of microduplications
often remains unsolved as the functional consequences
of these alterations are not well understood. However,
analyzing the role of the three genes included in the
rearrangement, namely ARHGAP28, LINC00668,
LAMA1, might help to elucidate, at least in part, the
genotype-phenotype relationship.
The ARHGAP28 encodes for a Rho GTPase activating
protein (RhoGAP) that switches RhoA into its inactive
form by stimulating the ability of Rho GTPase to
hydrolyze GTP to GDP. The Rho GTPases are important
in the regulation of reorganization of the actin during
the formation of stress fibers. In particular it has been
recently reported that in mice Arhgap28 might act as a
negative regulator of RhoA, during the formation of
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LINC00668 encodes for a long intergenic non coding
RNA whose function has not been reported but similarly
to the other non coding RNA it might be involved in the
regulation of gene expression.
Among the genes included in the duplication, the best
known is LAMA1 as it has also been found mutated in
humans and animal models. Laminins are a large family
of heterotrimeric glycoproteins consisting of a α, β and γ
chain present in the extracellular matrix, essential for
the basement membrane assembly and critical for early
embryonic development [15]. LAMA1 encodes for the
alpha-1 subunit of the Laminin-111 heterotrimer,
formed by α1, β1 and γ1. Hypomorphic and null
LAMA1 mutations in mice and zebrafish cause defects
in the retinal inner, limiting membrane development,
abnormal retinal blood vessel formation and progressive
cell loss from the inner nuclear and ganglion cell layers
[16, 17]. In humans, LAMA1 biallelic mutations have
been identified in patients affected by cerebellar dyspla-
sia with cysts, presenting defects in the retina develop-
ment, including retinal dystrophy, absent pigment and
atrophy [18]. However, both human and mice pheno-
types are determined by inactivating mutations with the
consequent absence of a functional product during
retinal and cerebellum development, whereas here we
detected a duplication of the gene containing region.
We can speculate that an excess of LAMA1 may be
involved in the cerebellum and retinal defects observed
in our patient by perturbing the interaction with the
other subunits in Laminin-111 formation, thus contrib-
uting to the cerebellar vermis hypoplasia and retinal
coloboma. Alternatively, the long intergenic non-coding
RNA (LINC00668) located downstream of the gene,
might be involved in LAMA1 transcription regulation
and the increased level of this non-coding transcript
might alter the local chromatin structure and conse-
quently affect transcription of the nearby genes [19].
Regarding the hearing loss, it is intriguing that lami-
nins have been detected at multiple sites in human and
rodent inner ears [20, 21]. Furthermore, the dy mouse, a
mutant model for congenital muscular dystrophy defect-
ive for laminin-α2, also presents hearing loss [22], thus
confirming the pleiotropic effect of laminins and reinfor-
cing the evidence of their involvement in deafness.
Although duplications encompassing LAMA1 are not
reported in the literature, seven patients with similar
partial or complete overlapping imbalances, including
this gene, are present in the DECIPHER [10] and ISCA
Databases [11] (Fig. 3c). Remarkably, some of these pa-
tients present clinical features resembling those observed
in our patient, such as hearing impairment in #285404
and #252483 and hearing impairment in association with
hypoplasia of the cerebellar vermis in #285404 orColoboma in nssv584041 and intellectual disability in
#252391. In all these patients, the minimal critical region
contains LAMA1 (Fig. 3c). However, against the involve-
ment of this duplication in the clinical phenotype is the
observation that duplications including LAMA1 also
represent rare CNVs as reported in the DGV [9].
In any case, the interpretation of the role of this dupli-
cation remains challenging, also considering the paucity
of similar rearrangements on 18p described in literature.
To the best of our knowledge, there are only three inter-
stitial submicroscopic duplications reported involving
18p and none of them overlaps with the one described
here [6–8]. In all of these cases, the microduplication
was either inherited from a healthy parent [7, 8], as in
the here presented case, or it was present in unaffected
family members [6], in accordance with a dominant
model of inheritance with incomplete penetrance. The
variability in the phenotype of patients carrying the same
unbalances, ranging from severe disorders to healthy
phenotype, might be explained with the presence of add-
itional anomalies in the affected patients. This additional
hit has been demonstrated in cases in which the aCGH
revealed the presence of a second rearrangement that
might operate through an additive model or by modify-
ing the phenotype [23]. Further studies are required to
establish the pathogenicity of this variation. Similarly to
other imbalances with reduced penetrance and variable
expressivity, it can be suspected that there might be
other co-occurring variations not detectable with con-
ventional aCGH. The complex phenotype of the here de-
scribed patient could be the consequence of different
and independent genetic defects and for example GHD
could be determined by a causative mutation in some
other gene.Additional file
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